Premenstrual disorders

被引:142
作者
Yonkers, Kimberly Ann [1 ,2 ,3 ]
Simoni, Michael K. [2 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA
关键词
menstrual cycle; premenstrual disorder; premenstrual dysphoric disorder; premenstrual symptoms; premenstrual syndrome; premenstrual tension; PHASE SERTRALINE TREATMENT; DYSPHORIC DISORDER; MENSTRUAL-CYCLE; ALLOPREGNANOLONE LEVELS; DOUBLE-BLIND; WOMEN; EFFICACY; SYMPTOMS; PREVALENCE; PLACEBO;
D O I
10.1016/j.ajog.2017.05.045
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Premenstrual disorders include premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual worsening of another medical condition. While the underlying causes of these conditions continue to be explored, an aberrant response to hormonal fluctuations that occurs with the natural menstrual cycle and serotonin deficits have both been implicated. A careful medical history and daily symptom monitoring across 2 menstrual cycles is important in establishing a diagnosis. Many treatments have been evaluated for the management of premenstrual disorders. The most efficacious treatments for premenstrual syndrome and premenstrual dysphoric disorder include serotonin reuptake inhibitors and contraceptives with shortened to no hormone-free interval. Women who do not respond to these and other interventions may benefit from gonadotropin-releasing hormone agonist treatment.
引用
收藏
页码:68 / 74
页数:7
相关论文
共 74 条
  • [21] Dennerstein Lorraine, 2012, Menopause Int, V18, P48, DOI 10.1258/mi.2012.012013
  • [22] Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome
    Di Carlo, C
    Palomba, S
    Tommaselli, GA
    Guida, M
    Sardo, AD
    Nappi, C
    [J]. FERTILITY AND STERILITY, 2001, 75 (02) : 380 - 384
  • [23] Daily Record of Severity of Problems (DRSP): reliability and validity
    Endicott, J
    Nee, J
    Harrison, W
    [J]. ARCHIVES OF WOMENS MENTAL HEALTH, 2005, 9 (01) : 41 - 49
  • [24] SSRIs probably counteract premenstrual syndrome by inhibiting the serotonin transporter
    Eriksson, Elias
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (02) : 173 - 174
  • [25] The hormonal causes of premenstrual tension
    Frank, RT
    [J]. ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1931, 26 (05): : 1053 - 1057
  • [26] An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome
    Freeman, Ellen W.
    Halbreich, Uriel
    Grubb, Gary S.
    Rapkin, Andrea J.
    Skouby, Sven O.
    Smith, Lynne
    Mirkin, Sebastian
    Constantine, Ginger D.
    [J]. CONTRACEPTION, 2012, 85 (05) : 437 - 445
  • [27] Freeman EW, 2002, EUR J CONTRACEP REPR, V7, P27
  • [28] The prevalence of premenstrual dysphoric disorder in a randomly selected group of urban and rural women
    Gehlert, S.
    Song, I. H.
    Chang, C. -H.
    Hartlage, S. A.
    [J]. PSYCHOLOGICAL MEDICINE, 2009, 39 (01) : 129 - 136
  • [29] Allopregnanolone Levels Before and After Selective Serotonin Reuptake Inhibitor Treatment of Premenstrual Symptoms
    Gracia, Clarisa R.
    Freeman, Ellen W.
    Sammel, Mary D.
    Lin, Hui
    Sheng, Li
    Frye, Cheryl
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (04) : 403 - 405
  • [30] PREMENSTRUAL DEPRESSION PREDICTS FUTURE MAJOR DEPRESSIVE DISORDER
    GRAZE, KK
    NEE, J
    ENDICOTT, J
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1990, 81 (02) : 201 - 205